Newly identified subsets of cell types present in joint tissue in people with rheumatoid arthritis and how they interact may explain why only some people respond to existing medications, according to two studies by co-senior ...
May 9, 2019
0
339
Heterotopic ossification (HO) is the formation of bone within soft tissue such as muscle, leading to pain and potentially the inability to use a limb. Once thought to be primarily a genetic disease, the cause of most trauma-induced ...
Apr 15, 2019
0
1
While current therapies for HIV can successfully manage active infection, the virus can survive in tissue reservoirs, including macrophage cells, and remain a persistent problem. Now, Dr. David Russell, William Kaplan Professor ...
Mar 25, 2019
0
122
Unique particles modified to mimic bacteria may provide a better means of treating infectious diseases, such as tuberculosis.
Mar 25, 2019
0
1
Current treatments for tuberculosis (TB) are very effective in controlling TB infection caused by Mycobacterium tuberculosis (Mtb). They don't, however, always prevent reinfection. Why this happens is one of the long-standing ...
Mar 22, 2019
0
59
Stanford scientists were able to engineer immune cells known as macrophages to detect and flag cancer in mice. The researchers hope the technique can be used for early cancer diagnostics in humans.
Mar 19, 2019
0
108
Cancer presents an ongoing challenge for physicians, particularly in the diagnosis and treatment of the disease. This is due to tumor heterogeneity, among other things. A team of scientists from the Helmholtz Zentrum Muenchen, ...
Mar 14, 2019
0
36
Scientists have recently recognized that cells of the same type can behave differently in response to stimulation. In a new study, Yale researchers have shown how these varied responses are due in part to a desynchronized ...
Mar 6, 2019
0
7
An international research team led by Friedrich Schiller University in Jena has developed a highly sensitive cell model to study the complex effects – and side effects – of anti-inflammatory drugs, with the ultimate aim ...
Feb 22, 2019
0
2
Developed by researchers at the University of Turku in Finland, an immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer. The antibody therapy prevented the growth ...
Feb 21, 2019
0
1
